117 related articles for article (PubMed ID: 1995447)
1. Antimicrosomal antibodies: what are they telling us?
Watkins PB
Hepatology; 1991 Feb; 13(2):385-7. PubMed ID: 1995447
[No Abstract] [Full Text] [Related]
2. Anti-liver microsomes autoantibodies and dihydralazine-induced hepatitis: specificity of autoantibodies and inductive capacity of the drug.
Bourdi M; Gautier JC; Mircheva J; Larrey D; Guillouzo A; Andre C; Belloc C; Beaune PH
Mol Pharmacol; 1992 Aug; 42(2):280-5. PubMed ID: 1513326
[TBL] [Abstract][Full Text] [Related]
3. Anti-liver endoplasmic reticulum autoantibodies are directed against human cytochrome P-450IA2. A specific marker of dihydralazine-induced hepatitis.
Bourdi M; Larrey D; Nataf J; Bernuau J; Pessayre D; Iwasaki M; Guengerich FP; Beaune PH
J Clin Invest; 1990 Jun; 85(6):1967-73. PubMed ID: 2347920
[TBL] [Abstract][Full Text] [Related]
4. Epitope mapping of human CYP1A2 in dihydralazine-induced autoimmune hepatitis.
Belloc C; Gauffre A; André C; Beaune PH
Pharmacogenetics; 1997 Jun; 7(3):181-6. PubMed ID: 9241657
[TBL] [Abstract][Full Text] [Related]
5. Anti-cytochrome P450 autoantibodies in drug-induced disease.
Beaune PH; Lecoeur S; Bourdi M; Gauffre A; Belloc C; Dansette P; Mansuy D
Eur J Haematol Suppl; 1996; 60():89-92. PubMed ID: 8987248
[TBL] [Abstract][Full Text] [Related]
6. [Cytochrome P450 isoenzymes and liver-kidney microsome antibodies. An antigen-antibody relationship].
Duclos-Vallée JC; Yamamoto AM; Cresteil D; Alvarez F
Gastroenterol Clin Biol; 1993; 17(12):908-12. PubMed ID: 8125222
[No Abstract] [Full Text] [Related]
7. Human anti-endoplasmic reticulum autoantibodies appearing in a drug-induced hepatitis are directed against a human liver cytochrome P-450 that hydroxylates the drug.
Beaune P; Dansette PM; Mansuy D; Kiffel L; Finck M; Amar C; Leroux JP; Homberg JC
Proc Natl Acad Sci U S A; 1987 Jan; 84(2):551-5. PubMed ID: 3540968
[TBL] [Abstract][Full Text] [Related]
8. Antigenic targets in tienilic acid hepatitis. Both cytochrome P450 2C11 and 2C11-tienilic acid adducts are transported to the plasma membrane of rat hepatocytes and recognized by human sera.
Robin MA; Maratrat M; Le Roy M; Le Breton FP; Bonierbale E; Dansette P; Ballet F; Mansuy D; Pessayre D
J Clin Invest; 1996 Sep; 98(6):1471-80. PubMed ID: 8823314
[TBL] [Abstract][Full Text] [Related]
9. A human cytochrome P-450 is recognized by anti-liver/kidney microsome antibodies in autoimmune chronic hepatitis.
Kiffel L; Loeper J; Homberg JC; Leroux JP
Biochem Biophys Res Commun; 1989 Feb; 159(1):283-9. PubMed ID: 2466461
[TBL] [Abstract][Full Text] [Related]
10. Target proteins in human autoimmunity: cytochromes P450 and UDP- glucuronosyltransferases.
Obermayer-Straub P; Strassburg CP; Manns MP
Can J Gastroenterol; 2000 May; 14(5):429-39. PubMed ID: 10851284
[TBL] [Abstract][Full Text] [Related]
11. Cytochromes P450 as targets to autoantibodies in immune mediated diseases.
Boitier E; Beaune P
Mol Aspects Med; 1999; 20(1-2):84-137. PubMed ID: 10575654
[No Abstract] [Full Text] [Related]
12. Autoantibodies against cytochrome P450s in sera of children treated with immunosuppressive drugs.
Lytton SD; Berg U; Nemeth A; Ingelman-Sundberg M
Clin Exp Immunol; 2002 Feb; 127(2):293-302. PubMed ID: 11876753
[TBL] [Abstract][Full Text] [Related]
13. Identification of human cytochrome P450s as autoantigens.
Manns MP; Johnson EF
Methods Enzymol; 1991; 206():210-20. PubMed ID: 1784210
[TBL] [Abstract][Full Text] [Related]
14. Major antigen of liver kidney microsomal autoantibodies in idiopathic autoimmune hepatitis is cytochrome P450db1.
Manns MP; Johnson EF; Griffin KJ; Tan EM; Sullivan KF
J Clin Invest; 1989 Mar; 83(3):1066-72. PubMed ID: 2466049
[TBL] [Abstract][Full Text] [Related]
15. Immunotoxicology and expression of human cytochrome P450 in microorganisms.
Beaune P; Bourdi M; Belloc C; Gautier JC; Guengerich FP; Valadon P
Toxicology; 1993 Oct; 82(1-3):53-60. PubMed ID: 8236281
[TBL] [Abstract][Full Text] [Related]
16. Cytochromes P-450 in human hepatocyte plasma membrane: recognition by several autoantibodies.
Loeper J; Descatoire V; Maurice M; Beaune P; Belghiti J; Houssin D; Ballet F; Feldmann G; Guengerich FP; Pessayre D
Gastroenterology; 1993 Jan; 104(1):203-16. PubMed ID: 7678237
[TBL] [Abstract][Full Text] [Related]
17. Expression of autoantibodies to specific cytochromes P450 in a case of disulfiram hepatitis.
Eliasson E; Stål P; Oksanen A; Lytton S
J Hepatol; 1998 Nov; 29(5):819-25. PubMed ID: 9833921
[TBL] [Abstract][Full Text] [Related]
18. [Hepatic lesions associated with antimicrosomal antibodies of the liver and kidney (type 2) and the taking of tienilic acid. A study of 37 cases].
Lafay JP; Poupon R; Legendre C; Homberg JC; Darnis F
Gastroenterol Clin Biol; 1983 May; 7(5):523-8. PubMed ID: 6873565
[No Abstract] [Full Text] [Related]
19. Enzyme-kinetic and immunochemical characteristics of mouse cDNA-expressed, microsomal, and purified CYP1A1 and CYP1A2.
Tsyrlov IB; Goldfarb IS; Gelboin HV
Arch Biochem Biophys; 1993 Dec; 307(2):259-66. PubMed ID: 8274012
[TBL] [Abstract][Full Text] [Related]
20. Identification of the epitope of an anti-peptide antibody which binds to CYP1A2 in many species including man.
Edwards RJ; Murray BP; Singleton AM; Murray S; Davies DS; Boobis AR
Biochem Pharmacol; 1993 Jul; 46(2):213-20. PubMed ID: 7688509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
